Cargando…
FNDC5 inhibits autophagy of bone marrow mesenchymal stem cells and promotes their survival after transplantation by downregulating Sp1
Regenerative therapy based on mesenchymal stem cells (MSCs) has great promise to achieve functional recovery in cerebral infarction patients. However, the survival rate of transplanted MSCs is extremely low because of destructive autophagy caused by the harsh ischemic microenvironment in cerebral in...
Autores principales: | Wei, Huan, Liu, Shuaiye, Wang, Tingting, Li, Yanping, Liu, Kangmei, Guo, Qunying, Li, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482879/ https://www.ncbi.nlm.nih.gov/pubmed/37673870 http://dx.doi.org/10.1038/s41420-023-01634-4 |
Ejemplares similares
-
FNDC5 overexpression promotes the survival rate of bone marrow mesenchymal stem cells after transplantation in a rat cerebral infarction model
por: Wei, Huan, et al.
Publicado: (2022) -
FNDC5/irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction
por: Deng, Jingyu, et al.
Publicado: (2020) -
Kartogenin Improves Osteogenesis of Bone Marrow Mesenchymal Stem Cells via Autophagy
por: Yan, Huichun, et al.
Publicado: (2022) -
Osteogenic effects of rapamycin on bone marrow mesenchymal stem cells via inducing autophagy
por: Xing, Yifeng, et al.
Publicado: (2023) -
Bone marrow mesenchymal stem cell-derived extracellular vesicles improve the survival of transplanted fat grafts
por: Huang, He, et al.
Publicado: (2017)